To Evaluate Safety, Tolerability and Pharmacokinetics of Single and multiple escalating doses of ONO-8055 in Healthy volunteers as a potential new therapy for Ulcerative Bladder

Trial Profile

To Evaluate Safety, Tolerability and Pharmacokinetics of Single and multiple escalating doses of ONO-8055 in Healthy volunteers as a potential new therapy for Ulcerative Bladder

Completed
Phase of Trial: Phase I

Latest Information Update: 17 Aug 2015

At a glance

  • Drugs ONO 8055 (Primary)
  • Indications Bladder dysfunction
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 17 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top